Xiu M - Search Results

1

Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia.

Guan X, Chen Y, Wang X, Xiu M, Wu F, Zhang X. Guan X, et al. Among authors: xiu m. Schizophr Res. 2024 Feb;264:81-86. doi: 10.1016/j.schres.2023.12.004. Epub 2023 Dec 18. Schizophr Res. 2024. PMID: 38113675

2

The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.

Zhang XY, Chen DC, Xiu MH, Wang F, Qi LY, Sun HQ, Chen S, He SC, Wu GY, Haile CN, Kosten TA, Lu L, Kosten TR. Zhang XY, et al. Schizophr Res. 2009 Sep;113(2-3):151-7. doi: 10.1016/j.schres.2009.05.016. Epub 2009 Jun 21. Schizophr Res. 2009. PMID: 19540723

3

Plasma total antioxidant status and cognitive impairments in schizophrenia.

Zhang XY, Chen DC, Xiu MH, Tang W, Zhang F, Liu L, Chen Y, Liu J, Yao JK, Kosten TA, Kosten TR. Zhang XY, et al. Schizophr Res. 2012 Aug;139(1-3):66-72. doi: 10.1016/j.schres.2012.04.009. Epub 2012 May 1. Schizophr Res. 2012. PMID: 22555016

4

Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study.

Zhang XY, Chen DC, Xiu MH, Haile CN, He SC, Luo X, Zuo L, Rosenheck R, Kosten TA, Kosten TR. Zhang XY, et al. Among authors: xiu mh. Psychol Med. 2013 Aug;43(8):1651-60. doi: 10.1017/S0033291712002590. Epub 2012 Nov 13. Psychol Med. 2013. PMID: 23149169 Clinical Trial.

5

Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.

Wu JQ, Chen DC, Tan YL, Tan SP, Wang ZR, Xiu MH, Yang FD, Zhang XY. Wu JQ, et al. Schizophr Res. 2014 Jan;152(1):210-6. doi: 10.1016/j.schres.2013.11.010. Epub 2013 Dec 8. Schizophr Res. 2014. PMID: 24325977

6

Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology.

Xiu MH, Yang GG, Tan YL, Chen DC, Tan SP, Wang ZR, Yang FD, Okusaga O, Soares JC, Zhang XY. Xiu MH, et al. Schizophr Res. 2014 Jun;156(1):9-14. doi: 10.1016/j.schres.2014.03.024. Epub 2014 Apr 22. Schizophr Res. 2014. PMID: 24766914

7

Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.

Wu JQ, Chen DC, Tan YL, Xiu MH, De Yang F, Soares JC, Zhang XY. Wu JQ, et al. Psychiatry Res. 2016 Apr 30;238:196-202. doi: 10.1016/j.psychres.2016.02.042. Epub 2016 Feb 18. Psychiatry Res. 2016. PMID: 27086233

8

Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.

Fu YY, Zhang T, Xiu MH, Tang W, Han M, Yun LT, Chen DC, Chen S, Tan SP, Soares JC, Tang WJ, Zhang XY. Fu YY, et al. Among authors: xiu mh. Schizophr Res. 2016 Oct;176(2-3):196-200. doi: 10.1016/j.schres.2016.05.010. Epub 2016 May 26. Schizophr Res. 2016. PMID: 27237600

9

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.

Chen DC, Du XD, Yin GZ, Yang KB, Nie Y, Wang N, Li YL, Xiu MH, He SC, Yang FD, Cho RY, Kosten TR, Soares JC, Zhao JP, Zhang XY. Chen DC, et al. Among authors: xiu mh. Psychol Med. 2016 Nov;46(15):3219-3230. doi: 10.1017/S0033291716001902. Epub 2016 Sep 8. Psychol Med. 2016. PMID: 27604840

10

Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.

Chen S, Tian L, Chen N, Xiu M, Wang Z, Yang G, Wang C, Yang F, Tan Y. Chen S, et al. Among authors: xiu m. Psychiatry Res. 2017 Jan;247:6-11. doi: 10.1016/j.psychres.2016.09.029. Epub 2016 Sep 22. Psychiatry Res. 2017. PMID: 27863321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters